<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="146319">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01938586</url>
  </required_header>
  <id_info>
    <org_study_id>SYDO-2013</org_study_id>
    <nct_id>NCT01938586</nct_id>
  </id_info>
  <brief_title>Comparison of Traditional Superficial Cutaneous Sutures Versus Steri-Strip Coaptive Film in Layered Dermatologic Closures</brief_title>
  <official_title>Comparison of Traditional Superficial Cutaneous Sutures Versus Steri-Strip Coaptive Film in Layered Dermatologic Closures on the Back - a Prospective, Randomized, Split-scar Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Henry Ford Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Henry Ford Health System</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the cosmetic outcome between buried intradermal and
      superficial cutaneous suture closures versus buried intradermal sutureand superficial
      Steri-Strip closures in the bilayered repair of dermatologic wounds on the back following
      elliptical excision of benign or malignant lesions
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <primary_completion_date type="Anticipated">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Overall scar appearance as evaluated by the Patient and Observer Scar Assessment Scale</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rates of postoperative complications</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Assessment of scar erythema, swelling, infection, drainage, dehiscence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time for closure of each split half portion of wound</measure>
    <time_frame>1 hour (intraoperative)</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Wound Cosmesis</condition>
  <arm_group>
    <arm_group_label>Surgical excision</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Steri-Strip</intervention_name>
    <arm_group_label>Surgical excision</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Superficial sutures</intervention_name>
    <arm_group_label>Surgical excision</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Outpatient dermatology clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years or greater in age

          -  Simple excision of benign or malignant lesion on the back

          -  Final scar length of at least 3cm

        Exclusion Criteria:

          -  Known history of keloid formation or hypertrophic scars

          -  Known adhesive allergy

          -  Pregnancy or active breast feeding
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sherry Yang, MD</last_name>
    <phone>313-916-2166</phone>
    <email>syang1@hfhs.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Henry Ford Dermatology Clinic</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Sherry Yang, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Ozog, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 5, 2013</lastchanged_date>
  <firstreceived_date>September 5, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Henry Ford Health System</investigator_affiliation>
    <investigator_full_name>David M. Ozog</investigator_full_name>
    <investigator_title>Director of Cosmetic Dermatology, Vice-Chair of Operations</investigator_title>
  </responsible_party>
  <keyword>Scar</keyword>
  <keyword>Appearance</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
